Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

cNeuro cMRI

K-Number: K171328 · 2018-01-08

ApplicantCombinostics OY
Decision Date2018-01-08
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

cNeuro cMRI is a medical device manufactured by Combinostics OY. It received FDA 510(k) clearance on 2018-01-08 under approval number K171328. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the cNeuro cMRI?

cNeuro cMRI is a medical device that received FDA 510(k) clearance on 2018-01-08. It is manufactured by Combinostics OY. The 510(k) number is K171328.

When was cNeuro cMRI approved by the FDA?

cNeuro cMRI received FDA 510(k) clearance on 2018-01-08, under approval number K171328.

What company makes cNeuro cMRI?

cNeuro cMRI is manufactured by Combinostics OY.

What is the FDA product code for cNeuro cMRI?

The FDA product code for cNeuro cMRI is LLZ.

Other Devices by Combinostics OY

K231576cNeuro cPET K233908cNeuro cDAT

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑